Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.31
BATS BZX Real-Time Price
As of 1:34pm ET
 -0.44 / -1.03%
Today’s Change
36.71
Today|||52-Week Range
44.85
+6.36%
Year-to-Date
Better Buy: Celldex Therapeutics, Inc. vs. Ionis Pharmaceuticals, Inc.
9:43am / MotleyFool.com - Paid Partner Content
Alnylam Rises After Ionis Partner Decides Not To Start Phase 3 Study
May 26 / TheStreet.com - Paid Partner Content
3 Value Stocks Near 52-Week Lows Worth Buying
May 27 / MotleyFool.com - Paid Partner Content
Glaxo/Innoviva Report Positive COPD Data on Relvar Ellipta
May 25 / Zacks.com - Paid Partner Content
Ionis Down, Glaxo Dumps IONIS-TTRRx Phase III Study Plans
May 27 / Zacks.com - Paid Partner Content
4 Safe Stocks With Dividend Yields Above 5%
May 25 / MotleyFool.com - Paid Partner Content
Why Alnylam Pharmaceuticals, Inc. Competed Higher Today
May 26 / MotleyFool.com - Paid Partner Content
PhaseRX: The Latest Pick From a Legendary VC Firm
May 24 / GuruFocus News - Paid Partner Content
Why Ionis Pharmaceuticals Plummeted Today
May 26 / MotleyFool.com - Paid Partner Content
Pfizer Champix's Label to Include More Data, Warning Lifted
May 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close42.75
Today’s open42.67
Day’s range42.25 - 42.74
Volume216,353
Average volume (3 months)3,568,899
Market cap$104.1B
Dividend yield5.52%
Data as of 1:34pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+13.86%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)-3.66%
P/E ratio168.4
Price/Sales2.70
Price/Book13.73

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.06+0.10%
SNYSanofi-0.14-0.34%
NVONovo Nordisk+0.54+0.97%
AGNAllergan-0.38-0.16%
Data as of 1:35pm ET, 05/31/2016

Financials

Next reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.60
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs